药理治疗急性单侧垂体病变:一篇评论
Francisco Alves de Sousa1, Clara Serdoura Alves1, Ana Nóbrega Pinto1
1Otorhinolaryngology and Head & Neck Surgery Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Journal of audiology & otology
|November 13, 2023
概括
急性单侧前庭病变 (AUV) 缺乏标准化的治疗方法. 目前的医疗管理涉及症状抑制剂和改善前体补偿的疗法,但证据有限且有争议.
科学领域:
- 神经学 神经学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性单侧带病 (AUV) 是一种关于其流行病学,病因学和医疗管理的研究有限的疾病.
- 目前的治疗方法侧重于缓解症状并增强中枢前庭补偿,但它们的疗效和潜在机制尚未完全理解.
研究的目的:
- 审查急性单侧静脉病变 (AUV) 的医疗治疗当前的发展和争议.
- 探索AUV的各种假设和治疗方法,包括药理干预.
主要方法:
- 对AUV流行病学,病因学和治疗现有研究的文献综述.
- 对药理干预的分析,包括前体抑制剂,抗,以及改善中枢前体补偿的药物.
- 讨论诸如皮质类固醇和抗病毒药物等有争议的治疗方法,以及缺乏针对血管向疗法的证据.
主要成果:
- 广泛的药物用于缓解AUV的症状,包括抗胆固醇药,类药,抗组胺药,抗多巴胺药,类药和通道抗剂.
- 诸如N-乙-L-氨酸,金科比洛巴和贝塔希斯之类的药物被认为可以改善中枢前庭补偿.
- 在AUV治疗中使用皮质类固醇和抗病毒药物是有争议的,一些证据表明对功能恢复的潜在危害. 针对血管的治疗方法缺乏经过验证的研究.
结论:
- 缺乏对AUV的标准化治疗方案.
- 对AUV的药理治疗仍然值得怀疑,有关各种药物的疗效和安全性的争议仍在继续.
- 需要进一步的研究来了解AUV病理生理学,并建立基于证据的治疗指南.
相关概念视频
Equilibrium and Balance
4.7K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.7K
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Open Angle Glaucoma: Treatment
459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
459
Angle Closure Glaucoma: Treatment
534
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
534
Direct-Acting Cholinergic Agonists: Therapeutic Uses
769
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
769
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698


